Biocleave’s aim is to make biological reagents accessible to pioneering life science researchers. To achieve this they have moved away from traditional protein expression technologies, and have established a brand-new recombinant protein expression host, capable of overcoming many of the limitations inherent in E. coli and eukaryotic systems. By combining the benefits of commercially proven, non-pathogenic, clostridial microbes with their world-leading genome engineering technologies, Biocleave are increasing the availability of previously difficult-to-express proteins. A further advantage afforded by their system – the proteins supplied by Biocleave are naturally endotoxin free.